Keywords: Noble gases; Chemically inert; Clinical applications; In vitro and in vivo studies; Drug delivery; CNS; central nervous system; logP; log of the octanol-water partition coefficient; L1; L2, Ostwald coefficients; DMPC; 1,2-dimyristoyl-sn-glycero-3-phosphoc
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Oligodendrocytes; Brain injury; Adult; Neonatal; Remyelination; Regeneration; Repair; Development; Pharmaceutical; CNS; Central nervous system; WM; white matter; OPC; oligodendrocyte progenitor cell; OL; oligodendrocyte; SVZ; subventricular zone; EAE; exp
Keywords: AES; American Epilepsy Society; ASD; anti-seizure drug; ASP; Anticonvulsant Screening Program; BLA; basolateral amygdala; CC; convulsant current; CD; convulsive dose; BBB; blood-brain barrier; CNS; central nervous system; ED; effective dose; ETSP; Epileps
Keywords: Inhalants; Alkylbenzenes; Seizures; Death; NMDA; PTZ;
Keywords: Aβ; amyloid-β; AβO; Aβ oligomers; βAPP; β-amyloid precursor protein; BDNF; brain-derived neurotrophic factor; CaMKII; calcium/calmodulin-dependent protein kinase II; Cer; cerebellum; ChAT; choline acetyltransferase; Cx; cortex; CxFr; cortex frontal;
Keywords: Anesthesia; Auditory cortex; Flavoprotein fluorescent imaging; Ketamine; Laminar structure; Medetomidine-midazolam-butorphanol; A1; primary auditory cortex; AAF; anterior auditory field; AC; auditory cortex; BW; bandwidth; CF; characteristic frequency; CS
Keywords: Molecular receptors; Nanoprobes; Nanosensors; Nanochips; Drug screening; Nanomaterials; DFC; Drug-facilitated crime; UNODC; United Nations Office on Drugs and Crime; GC/MS; Gas Chromatography/Mass Spectrometry; LC/MS; Liquid Chromatography/MS; HPTLC; High
Keywords: AMPA; α-amino-3-hydroxy-5-methylisoxazole-4-propionate; CB1R; type 1 cannabinoid receptor; Cbln-1; precerebellin; CF-LTD; climbing fiber long term depression; CF-PC; climbing fiber-Purkinje cell; E; embryonic day; LTD; long term depression; LTP; long ter
Keywords: Bv8; Prokineticins; Oxygen-glucose deprivation; Preconditioning; Ischemic tolerance; Neuroprotection; PK2; prokineticin 2; PKR; PK receptor; PKR1; PK receptor 1; PKR2; PK receptor 2; PC7; (2-(5-(4-fluorobenzyl)-1-(4-methoxybenzyl)-1,4,5,6-tetrahydro-4,6-d
Keywords: AD; Alzheimer's disease; T2DM; type II diabetes mellitus; Aβ; amyloid beta; NFT; neurofibrillary tangles; IR; insulin resistance; InsR; insulin receptors; IRS; InsR substrate; IGF; insulin growth factor; ICV; intracerebroventricular; STZ; streptozotocin;
Keywords: Fear conditioning; Novelty seeking; Individual differences; Fear extinction; Ketamine; Fear memory reconsolidation; ACC; anterior cingulate cortex; Bdnf; brain-derived neurotrophic factor; BLA; basolateral amygdala; CA1; cornu ammonis 1; CA3; cornu ammoni
Keywords: BDNF; brain-derived neurotrophic factor; CAPRIN1; cell cycle associated protein 1; CD3D; CD3d molecule delta; CD97; CD97 molecule; CHL1; cell adhesion molecule L1-like; CLEC4A; C-type lectin domain family 4, member A; CNVs; copy-number variations; DUSP1;
Keywords: AIDS; acquired immunodeficiency virus; ANI; asymptomatic neurocognitive impairment; BBB; blood brain barrier; BDNF; brain derived neurotrophic factor; cART; combination antiretroviral therapy; CDC; Centers for Disease Control and Prevention; CNS; central
Keywords: Cellular viability; Creatine; Glutamate; Hydrogen peroxide; Nitric oxide; MTT; 3-(4,5-dimethylthiazol-2-yl-diphenyltetrazolium bromide); DCF; dichlorofluorescein; MK-801; Dizocilpine; DMEM; Dulbecco's modified Eagle's medium; DMSO; dimethylsulfoxide; H2O2
Keywords: AMPA; 2-amino-3(3-hydroxy-5-methyl-isoxazol-4yl)propanoic acid; BNST; bed nucleus of the stria terminalis; CeA; central nucleus of the amgydala; CSF; cerebrospinal fluid; DLS; dorsolateral striatum; DMS; dorsomedial striatum; EC; external capsule; EPSP; e
Keywords: Alzheimer's disease; Amyloid-β; β-secretases; γ-secretases; Computer-Aided Drug Design; AD; Alzheimer's disease; Aβ1-40; beta-Amyloid isoform 40 amino acids in length; Aβ1-42; beta-Amyloid isoform 42 amino acids in length; NMDA; N-Methyl-d-aspart
Keywords: Ac-H3; acetylated histone H3; Actb; β-actin; ALS; amyotrophic lateral sclerosis; BA; butyric acid; BA3G; glyceryl tributyrate; b.i.d.; bis in die; CNS; central nervous system; CREB; cAMP responsive element-binding protein; FL-SMN; full-length survival mo
Keywords: Aβ; β-Amyloid peptide; Aβ40; 40-amino acid isoform of β-Amyloid peptide; Aβ42; 42-amino acid isoform of β-Amyloid peptide; Aβ42/Aβ40; ratio of measured steady-state levels of Aβ42 and Aβ40; AD; Alzheimer's Disease; AICD; APP intracellular domain
Keywords: Nitro compounds; Natural products; Pharmaceuticals; Stereoselective synthesis; Organocatalysis; Metal catalysis; Nitronates; Nitrile oxides; AIBN; azobisisobutyronitrile; AZADO; 2-azaadamantane-N-oxyl; 9-BBN; 9-borabicyclo[3.3.1]nonane; BINAP; 2,2â²-bis(
Keywords: AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; AUD; alcohol use disorder; FDA; Food and Drug Administration; GABAAR; γ-aminobutyric acid receptor; NAc; nucleus accumbens; nAChRs; nicotinic acetylcholine receptors; NMDA; N-methyl-d-aspartate
Keywords: AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; Apaf-1; apoptotic protease activating factor 1; CAD; caspase-activation DNase; cyt c; cytochrome c; Cy; cyclophilin; Drp-1; dynamin-related protein 1; ENDO; endonuclease; AIF; apoptosis-inducing
Keywords: CH; chloral hydrate; CPP; conditioned place preference; 5-HT; 5-hydroxytryptamine; ANOVA; analysis of variance; LSD; least significant difference; NS; no significance; NMDA; N-methyl-D-aspartate; i.p; intraperitoneal; S.E.M.; standard error of the mean; M
Keywords: CSF; cerebrospinal fluid; IL-1; interleukin-1; IL-6; interleukin-6; NMDA; N-methyl-d-aspartate; TNF-α; tumor necrosis factor alpha; Ketamine; NMDA receptor; Immune system; Depression;
Keywords: CAT; cysteine aminotransferase; CBS; cystathionine β-synthase; CO; carbon monoxide; CSE; cystathionine γ-lyase; DAO; d-amino acid oxidase; ERK; extracellular signal-regulated kinase; eNOS; endothelial nitric oxide synthase; GSH; reduced form of glutathi
Keywords: Stress; Noradrenaline; Corticosterone; Synapses; Long-term potentiation; AMPA; NMDA;
Keywords: Actin; ARC, Genetics; NMDA; Schizophrenia; Synapse
Keywords: Estrogen; Progesterone; Testosterone; Epilepsy; GABA; NMDA
Keywords: Depression; Quercetin; Olfactory bulbectomy; NMDA; Nitric oxide; Oxidative stress;
Keywords: Fragile X; FMRP; Fmr1; Hippocampus; Dentate gyrus; Synaptic plasticity; LTP; NMDA; Stress
Keywords: DA; dopamine; TBI; traumatic brain injury; SN; substantia nigra; NMDA; N-methyl-d-aspartate; FJC; Fluoro-Jade C; HVA; homovanillic acid; DOAPC; 3, 4-dihydroxyphenylacetic acid; HPLD-ECD; high-performance liquid chromatography-eletochemical; TH; tyrosine h
Keywords: AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; CR; calretinin; GABAA; gamma-aminobutyric acid type-A; K(Ca); calcium-dependent potassium; Nap; persistent sodium; NMDA; N-methyl-d-aspartate; PFC; prefrontal cortex; PV; parvalbumin; SD; standa
Keywords: PAS; paired associative stimulation; M1; motor cortex; TMS; transcranial magnetic stimulation; MRS; magnetic resonance spectroscopy; GABA; γ-aminobutyric acid; NAA; N-acetylaspartate; Cr; creatine; Cho; choline; OCC; occipital cortex; PMEPs; pharyngeal m
Keywords: API; active pharmaceutical ingredient; CBQCA; 3-(4-carboxybenzoyl)quinolone-2-carboxaldehyde; DMSO; dimethyl sulfoxide; DOE; design of experiments; EDQM; European Directorate for the Quality of Medicines & HealthCare; FLD; fluorescence detection; HP-β-CD
Keywords: virus; encephalitis; seizures; epidemiology; autoimmune encephalitis; acute disseminated encephalomyelitis; NMDA
Keywords: Apoptosis; HDAC5; CaMKII; Histone acetylation; Neuron; NMDA
Keywords: ARND; age related neurodegenerative diseases; AD; Alzheimer's disease; ALS/PDC; amyotrophic lateral sclerosis-Parkinsonism dementia complex of Guam; BBB; blood brain barrier; BMAA; β-methylamino-l-alanine; CNS; central nervous system; CSF; cerebrospina
Keywords: AD; Alzheimer's disease; Aβ; amyloid-β; NFTs; neurofibrillary tangles; p-tau; hyperphosphorylated tau; ROS; reactive oxygen species; [Zn2 +]i; intraneuronal Zn2 +; [Ca2 +]i; intraneuronal Ca2 +; m.o; month old; m.o.a; months of age; i.p; intraperito
Keywords: Radial arm maze; Neurotransmitter receptor complex; Blue native PAGE; Spatial memory; D1-GluN1 complex; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; NMDA; N-methyl-D-aspartic acid; PAGE; Polyacrylamide gel electrophoresis;
Keywords: Aging; Spatial memory; Glutamate receptors; AMPA; NMDA; mGluR; VGLUT;
Keywords: AD; amygdala; ANOVA; analysis of variance; CMS; chronic mild stress; FST; forced swimming test; GD; gestational day; GluR; glutamate receptor; HIP; hippocampus; iGluRs; ionotropic glutamate receptors; mGluRs; metabotropic glutamate receptors; NMDA; N-meth
Keywords: CNS; central nervous system; INS-1; insulin secreting β-cell line originated from a rat insulinoma; GK rat; Goto-Kakizaki rat; NOD mouse; non-obese diabetic mouse; TKP; tryptophan/kynurenine pathway; Trp; tryptophan; KYN; kynurenine; 3HK; 3-OH-kynureni
Keywords: IASP; International Association for the Study of Pain; NMDA; N-methyl-d-aspartate; VAS; Visual Analogue Scale; NRS; Numerical Rating Scale; RR; relative risk; CI; confidence interval; POCP; postoperative chronic pain; Intra- and postoperative ketamine; Ch
Keywords: BCAA; branched-chain amino acids; BID; twice daily; GABA-A; γ-aminobutyric acid type A; HE; hepatic encephalopathy; MELD; Model for End-Stage Liver Disease; NMDA; N-methyl-d-aspartate receptor; q2-q4; every 2-4 hours; ROS; reactive oxygen species; TID; 3
Keywords: AM; acetoxymethyl ester; PF127; pluronic F127; DMSO; dimethyl sulfoxide; OTCs; organotypic cultures; APV; dl-2-amino-5-phosphonovaleric acid; CNQX; 6-cyano-7-nitroquinoxaline-2,3-dione; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; NMDA; N-
Keywords: 4-AP; 4-aminopyridine; ACC; anterior cingulate cortex; aCSF; artificial cerebral spinal fluid; ANOVA; analysis of variance; APV; D-1-2-amino-5-phosphonopentanoic acid; ATP; adenosine triphosphate; BDNF; brain-derived neurotrophic factor; CSD; current-sour
Keywords: ANOVA; analysis of variance; Con; Control; con-Mino; control-minocycline; con-Nacl; control-Nacl; EEG; electroencephalographic; ELISA; enzyme-linked immunosorbent assay; GABA; γ-aminobutyric acid; GFAP; glial fibrillary acidic protein; Iba1; ionized calc
Keywords: AC; acid ceramidase; ACTH; adrenocorticotropic hormone; AMPA; alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; ASM; acid sphingomyelinase; BDNF; brain-derived nerve growth factor; CB1; cannabinoid 1 receptor; CDP-DAG; cytidine diphosphate diacylg
Keywords: ANOVA; analysis of variance; BDNF; Brain-derived neurotrophic factor; CORT; corticosterone; CS; conditioning stimulus; GR; glucocorticoid receptor; HET; heterozygous; HET CORT; HET rats receiving CORT; HPA; hypothalamic-pituitary axis; MR; mineralocorti
Keywords: ADX; adrenalectomized; ASD; autism spectrum disorders; BD; bipolar disorder; CSF; cerebrospinal fluid; DAMPs; damage-associated molecular patterns; FS; forced swimming; HDACi; histone deacetylase inhibitor; HSP; heat shock protein; IDO; indoleamine 2,3 di
Keywords: CHEP; contact heat-evoked potential; CNS; central nervous system; CPRS; complex regional pain syndrome; LEP; laser-evoked potential; NMDA; N-methyl-d-aspartate; NNT; number needed to treat; QSART; quantitative sudomotor axon reflex test; RCT; randomized